Abstract
Intracoronary (IC) delivery of cardiosphere–derived cells (CDCs) has been demonstrated to be safe and effective in porcine and human ischemic cardiomyopathy. However, IC delivery of CDCs promptly after reperfusion has never been assessed in a clinically–relevant large animal model. We tested the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
